Ludovic Samalin

Prof. Ludovic Samalin


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2013 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
PLPierre-Michel Llorca
Pierre-Michel Llorca
MAMocrane Abbar
Mocrane Abbar
PCPhilippe Courtet
Philippe Courtet
SGSébastien Guillaume
Sébastien Guillaume
SLSylvie Lancrenon
Sylvie Lancrenon
LSLudovic Samalin
Ludovic Samalin
Background: Long-acting injectable (LAI) formulations are not widely used in routine practice even though they offer advantages in terms of relapse prevention. As part of a process to improve the quality of care, the French Association for Biological Psychiatry and Neuropsychopharmacology (AFPBN) elaborated guidelines for the use and management of antipsychotic depots in clinical practice. Methods: Based on a literature review, a written survey was prepared that asked about 539 options in 32 specific clinical situations concerning 3 fields: target-population, prescription and use, and specific populations. We contacted 53 national experts, 42 of whom (79%) completed the survey. The options were scored using a 9-point scale derived from the Rand Corporation and the University of California in the USA. According to the answers, a categorical rank (first-line/preferred choice, second-line/alternate choice, third-line/usually inappropriate) was assigned to each option. The first-line option was defined as a strategy rated as 7–9 (extremely appropriate) by at least 50% of the experts. The following results summarize the key recommendations from the guidelines after data analysis and interpretation of the results of the survey by the scientific committee. Results: LAI antipsychotics are indicated in patients with schizophrenia, schizoaffective disorder, delusional disorder and bipolar disorder. LAI second-generation antipsychotics are recommended as maintenance treatment after the first episode of schizophrenia. LAI first-generation antipsychotics are not recommended in the early course of schizophrenia and are not usually appropriate in bipolar disorder. LAI antipsychotics have long been viewed as a treatment that should only be used for a small subgroup of patients with non-compliance, frequent relapses or who pose a risk to others. The panel considers that LAI antipsychotics should be considered and systematically proposed to any patients for whom maintenance antipsychotic treatment is indicated. Recommendations for medication management when switching oral antipsychotics to LAI antipsychotics are proposed. Recommendations are also given for the use of LAI in specific populations. Conclusion: In an evidence-based clinical approach, psychiatrists, through shared decision-making, should be systematically offering to most patients that require long-term antipsychotic treatment an LAI antipsychotic as a first-line treatment.

12 October 2020 in Journal of Behavioral Addictions
Verified
Journal Article
Open access
PDF file
VFValentin Flaudias
Valentin Flaudias
Sylvain IcetaSylvain Iceta
Sylvain Iceta
OZOulmann Zerhouni
Oulmann Zerhouni
RRRachel Rodgers
Rachel Rodgers
JBJoel Billieux
Joel Billieux
SGSébastien Guillaume
Sébastien Guillaume
Background and aims: Since mid-March 2020, over 3 billion people have been confined as a result of the COVID-19 pandemic. Problematic eating behaviors are likely to be impacted by the pandemic through multiple pathways. This study examined the relationships between stress related to lockdown measures and binge eating and dietary restriction in a population of French students during the first week of confinement.Methods: A sample of undergraduate students (N = 5,738) completed an online questionnaire 7 days after lockdown measures were introduced. The survey comprised variables related to lockdown measures and the COVID-19-pandemic, mood, stress, body image, binge eating and dietary restriction during the past 7 days, as well as intent to binge eat and restrict in the following 15 days.Results: Stress related to the lockdown was associated with greater likelihood of binge eating and dietary restriction over the past week and intentions to binge eat and restrict over the next 15 days. Greater exposure to COVID-19-related media was associated with increased eating restriction over the past week. Binge eating and restriction (past and intentions) were associated with established risk factors, including female gender, low impulse regulation, high body dissatisfaction, and having a concurrent probable eating disorder.Discussion and conclusion: The higher the stress related to the first week of confinement, the higher the risk of problematic eating behaviors among students, particularly those characterized by eating-related concerns. Screening for risk factors and providing targeted interventions might help decrease problematic eating behaviors among those who are most vulnerable.

6 March 2016 in Bipolar Disorders
Verified
Journal Article
Closed access
PDF file
LSLudovic Samalin
Ludovic Samalin
ICIngrid de Chazeron
Ingrid de Chazeron
Eduard VietaEduard Vieta
Eduard Vieta
FBFrank Bellivier
Frank Bellivier
PLPierre‐Michel Llorca
Pierre‐Michel Llorca

1 March 2017 in Journal of Affective Disorders
Verified
Journal Article
Closed access
LSLudovic Samalin
Ludovic Samalin
LBLaurent Boyer
Laurent Boyer
AMAndrea Murru
Andrea Murru
IPIsabella Pacchiarotti
Isabella Pacchiarotti
MRMaría Reinares
María Reinares
Eduard VietaEduard Vieta
Eduard Vieta

17 February 2022 in International Journal of Psychiatry in Clinical Practice
Verified
Journal Article
Open access
LSLudovic Samalin
Ludovic Samalin
MRMaud Rothärmel
Maud Rothärmel
LMLila Mekaoui
Lila Mekaoui
EGEmeline Gaudré-Wattinne
Emeline Gaudré-Wattinne
MCMarie-Alix Codet
Marie-Alix Codet
ASAnne Sauvaget
Anne Sauvaget
To present the first real-world data of patients with treatment-resistant depression (TRD) treated with esketamine through a French cohort Temporary Authorisation for Use (ATUc) programme.In 2019, ...

4 May 2023 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
OPOmkar Ramesh Patil
Omkar Ramesh Patil
YZYuezhou Zhang
Yuezhou Zhang
VGVibhuti Gupta
Vibhuti Gupta
STSalvatore Tedesco
Salvatore Tedesco
GAGerard Anmella
Gerard Anmella
DHDiego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
Background: Depressive and manic episodes within bipolar disorder (BD) and major depressive disorder (MDD) involve altered mood, sleep, and activity, alongside physiological alterations wearables can capture. Objective: Firstly, we explored whether physiological wearable data could predict (aim 1) the severity of an acute affective episode at the intra-individual level and (aim 2) the polarity of an acute affective episode and euthymia among different individuals. Secondarily, we explored which physiological data were related to prior predictions, generalization across patients, and associations between affective symptoms and physiological data. Methods: We conducted a prospective exploratory observational study including patients with BD and MDD on acute affective episodes (manic, depressed, and mixed) whose physiological data were recorded using a research-grade wearable (Empatica E4) across 3 consecutive time points (acute, response, and remission of episode). Euthymic patients and healthy controls were recorded during a single session (approximately 48 h). Manic and depressive symptoms were assessed using standardized psychometric scales. Physiological wearable data included the following channels: acceleration (ACC), skin temperature, blood volume pulse, heart rate (HR), and electrodermal activity (EDA). Invalid physiological data were removed using a rule-based filter, and channels were time aligned at 1-second time units and segmented at window lengths of 32 seconds, as best-performing parameters. We developed deep learning predictive models, assessed the channels’ individual contribution using permutation feature importance analysis, and computed physiological data to psychometric scales’ items normalized mutual information (NMI). We present a novel, fully automated method for the preprocessing and analysis of physiological data from a research-grade wearable device, including a viable supervised learning pipeline for time-series analyses. Results: Overall, 35 sessions (1512 hours) from 12 patients (manic, depressed, mixed, and euthymic) and 7 healthy controls (mean age 39.7, SD 12.6 years; 6/19, 32% female) were analyzed. The severity of mood episodes was predicted with moderate (62%-85%) accuracies (aim 1), and their polarity with moderate (70%) accuracy (aim 2). The most relevant features for the former tasks were ACC, EDA, and HR. There was a fair agreement in feature importance across classification tasks (Kendall W=0.383). Generalization of the former models on unseen patients was of overall low accuracy, except for the intra-individual models. ACC was associated with “increased motor activity” (NMI>0.55), “insomnia” (NMI=0.6), and “motor inhibition” (NMI=0.75). EDA was associated with “aggressive behavior” (NMI=1.0) and “psychic anxiety” (NMI=0.52). Conclusions: Physiological data from wearables show potential to identify mood episodes and specific symptoms of mania and depression quantitatively, both in BD and MDD. Motor activity and stress-related physiological data (EDA and HR) stand out as potential digital biomarkers for predicting mania and depression, respectively. These findings represent a promising pathway toward personalized psychiatry, in which physiological wearable data could allow the early identification and intervention of mood episodes.